Influence of thyroid dysfunctions on pregnancy: a systematic analysis of evidence
DOI:
https://doi.org/10.33448/rsd-v14i11.49861Keywords:
Pregnancy, Thyroid Diseases, Hypothyroidism, Pregnancy Complications, Pregnancy, High-Risk, Prenatal Care.Abstract
Introduction: Prenatal care is essential for identifying thyroid disorders, such as hypothyroidism and hyperthyroidism, which can cause pregnancy complications. Selective screening is recommended, but it may lead to underdiagnosis of cases, while universal screening may improve maternal-fetal outcomes. Objective: To analyze the impact of prenatal screening for thyroid dysfunction on pregnancy outcomes in pregnant women. Method: Systematic review conducted from March to November 2024. The following inclusion criteria were adopted for study selection: primary studies published in the last decade, available in English and/or Portuguese, in the following databases: Virtual Health Library, PubMed/MEDLINE, SciELO, and Web of Science. After synthesis, the data were presented in tables containing the information necessary for the research objective. Results: The initial search identified 676 articles, and after selection and screening, eight studies remained for final inclusion. Hypothyroidism in pregnancy was associated with an increased risk of gestational hypertension, preeclampsia, eclampsia, preterm birth, and spontaneous abortion, especially with TSH > 4 mU/L. Treatment of hypothyroidism reduced these risks. Universal screening detected more cases than screening based on risk factors, showing the benefit of comprehensive screening programs. Conclusion: Studies indicate that universal screening for thyroid dysfunction in pregnancy can improve management and reduce complications, especially in cases of clinical hypothyroidism. However, the effects of subclinical hypothyroidism are less clear, and the effectiveness of treating mild conditions is questioned.
References
Aghajanian, P., Spencer, C. A., Wilson, M. L., Lee, R. H., Goodwin, T. M., & Mestman, J. H. (2015). Evaluation of risk-factor-based screening for thyroid peroxidase antibody positivity in pregnancy. Clinical Endocrinology, 84(3), 417–422.
Ahmed, I. Z., Eid, Y. M., El Orabi, H., & Ibrahim, H. R. (2017). Comparison of universal and targeted screening for thyroid dysfunction in pregnant Egyptian women. European Journal of Endocrinology, 171(2), 285–291.
Alexander, E. K., Pearce, E. N., Brent, G. A., Brown, R. S., Chen, H., Dosiou, C., et al. (2017). 2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum. Thyroid, 27(3), 315–389.
Brasil. Ministério da Saúde. (2016). Protocolos da Atenção Básica: Saúde das Mulheres. Ministério da Saúde, Instituto Sírio-Libanês de Ensino e Pesquisa.
Brasil. Ministério da Saúde. Secretaria de Atenção Primária à Saúde. Departamento de Ações Programáticas. (2022). Manual de gestação de alto risco.
Bryant, S. N., Nelson, D. B., McIntire, D. D., Casey, B. M., & Cunningham, F. G. (2015). An analysis of population-based prenatal screening for overt hypothyroidism. American Journal of Obstetrics and Gynecology, 213(4), 565.e1–565.e6.
Couto, E., & Cavichiolli, F. (2019). Doenças da tireoide na gestação. Femina, 47(6), 323–327.
Dosiou, C., & Medici, M. (2017). Management of endocrine disease: Isolated maternal hypothyroxinemia during pregnancy: Knowns and unknowns. European Journal of Endocrinology, 176(1), R21–R38.
Gong, X., Liu, A., Li, Y., Sun, H., Li, Y., Li, C., et al. (2019). The impact of isolated maternal hypothyroxinemia during the first and second trimester of gestation on pregnancy outcomes: An intervention and prospective cohort study in China. Journal of Endocrinological Investigation, 42(5), 599–607.
Joanna Briggs Institute (JBI). (2020). Critical appraisal tools [Internet]. https://jbi.global/critical-appraisal-tools.
Jouyandeh, Z., Hasani-Ranjbar, S., Qorbani, M., & Larijani, B. (2014). Universal screening versus selective case-based screening for thyroid disorders in pregnancy. Endocrine, 48(1), 116–123.
Lee, S. Y., Cabral, H. J., Aschengrau, A., & Pearce, E. N. (2019). Associations between maternal thyroid function in pregnancy and obstetric and perinatal outcomes. The Journal of Clinical Endocrinology & Metabolism, 105(5), e2015–e2023.
Lima F. J., Gomes, M., & Maria Príncipe, R. (2020). Controversial screening for thyroid dysfunction in preconception and pregnancy: An evidence-based review. Journal of Family & Reproductive Health, 14(4), 209–220.
Ma, L., Qi, H., Chai, X., Jiang, F., Mao, S., Liu, J., et al. (2016). The effects of screening and intervention of subclinical hypothyroidism on pregnancy outcomes: A prospective multicenter single-blind, randomized, controlled study of thyroid function screening test during pregnancy. Journal of Maternal-Fetal & Neonatal Medicine, 29(9), 1391–1394.
Maganha, C. A., Mattar, R., Mesa Júnior, C. O., Marui, S., Solha, S. T., Teixeira, P. F., et al. (2022). Rastreio, diagnóstico e manejo do hipertireoidismo na gestação. Femina, 50(8), 481–489.
Nazarpour, S., Ramezani Tehrani, F., Simbar, M., Tohidi, M., Alavi Majd, H., & Azizi, F. (2017). Effects of levothyroxine treatment on pregnancy outcomes in pregnant women with autoimmune thyroid disease. European Journal of Endocrinology, 176(2), 253–265.
Ong, G. S. Y., Hadlow, N. C., Brown, S. J., Lim, E. M., & Walsh, J. P. (2014). Does the thyroid-stimulating hormone measured concurrently with first trimester biochemical screening tests predict adverse pregnancy outcomes occurring after 20 weeks gestation? The Journal of Clinical Endocrinology & Metabolism, 99(12), E2668–E2672.
Page, M. J., Moher, D., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., et al. (2021). PRISMA 2020 explanation and elaboration: Updated guidance and exemplars for reporting systematic reviews. BMJ, 372, n160.
Pereira, A. S. et al. (2018). Metodologia da pesquisa científica. [free ebook]. Santa Maria. Editora da UFSM.
Santos, C. M. C., Pimenta, C. A. M., & Nobre, M. R. C. (2007). The PICO strategy for the research question construction and evidence search. Revista Latino-Americana de Enfermagem, 15(3), 508–511.
Sgarbi, J. A., Teixeira, P. F. S., Maciel, L. M. Z., Mazeto, G. M. F. S., Vaisman, M., Montenegro Junior, R. M., et al. (2013). Consenso brasileiro para a abordagem clínica e tratamento do hipotireoidismo subclínico em adultos: Recomendações do Departamento de Tireoide da Sociedade Brasileira de Endocrinologia e Metabologia. Arquivos Brasileiros de Endocrinologia & Metabologia, 57(3), 166–183.
Shanqeeti, S. A. A., Alkhudairy, Y. N., Alabdulwahed, A. A., Ahmed, A. E., Al-Adham, M. S., & Mahmood, N. M. (2018). Prevalence of subclinical hypothyroidism in pregnancy in Saudi Arabia. Saudi Medical Journal, 39(3), 254–260.
Solha, S. T., Mattar, R., Teixeira, P. F., Chiamolera, M. I., Maganha, C. A., Zaconeta, A. C., et al. (2022). Rastreio, diagnóstico e manejo do hipotireoidismo na gestação. Femina, 50(10), 607–617.
Taylor, P. N., Okosieme, O. E., Premawardhana, L., & Lazarus, J. H. (2015). Should all women be screened for thyroid dysfunction in pregnancy? Women’s Health, 11(3), 295–307.
Taylor, P. N., Zouras, S., Min, T., Nagarahaj, K., Lazarus, J. H., & Okosieme, O. (2018). Thyroid screening in early pregnancy: Pros and cons. Frontiers in Endocrinology, 9, 626.
Van der Spek, A. H., & Bisschop, P. H. (2020). Universal screening for thyroid disease should not be recommended before and during pregnancy. Best Practice & Research Clinical Endocrinology & Metabolism, 34(4), 101429.
Zhang, Y., Li, Y., Shan, Z., Xu, Y., Li, C., Xie, X., et al. (2019). Association of overt and subclinical hyperthyroidism during weeks 4–8 with adverse pregnancy outcomes. Journal of Women’s Health, 28(6), 842–848.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Carlos Eduardo Oliveira da Silva, Luiza Maciel Milanez, Valéria Correa Nunes, Cecília Harumi Martins Hatano, Leila Maués Oliveira Hanna
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
